Chromatin, Inc., based in Chicago, Illinois, USA, develops renewable energy-crop feedstocks for power, fuel and chemical producers. It is also serves the supply chains of fuel and chemical producers and is developing by developing high-value next-generation sorghum seeds for growers using its proprietary crop-breeding technology and biotechnology programs.
Its proprietary gene stacking technology enables the design of entire chromosomes that can be transplanted into plant cells.
The company licenses its innovative technologies to support the crop breeding programs of leading agricultural companies, and it applies these technology platforms to its subsidiary, Sorghum Partners LLC, which produces and markets hybrid sorghum seeds to growers in the US and more than 20 other countries.
CEO and a co-founder Daphne Preuss leads the company. Prior to Chromatin, she led a research laboratory at the Howard Hughes Medical Institute and the University of Chicago, which trailblazed discoveries that led to synthetic chromosomes in plants. She serves on Board of the Biotechnology Industry Organization and is a member of its Food & Agriculture Governing Section Board. Preuss earned a Ph.D. from MIT, and performed postdoctoral work at Stanford.
Chief Technology Officer David Jessen has more than 26 years of experience spearheading agricultural biotechnology product development. Before joining Chromatin, Jessen was Head of Traits & Technology for Corn and Soy at Syngenta A.G. where he held several strategic leadership roles over the years. He was also Vice President of Research and Development at Novartis Seeds, Inc.